Drug firm Dr Reddy's Laboratories today said it has signed a pact with Russia-based R-Pharm for co-development of high technology products and collaboration in manufacturing and marketing.
The company has entered into a licencing, technology transfer, manufacturing and marketing agreement with R-Pharm of Russia, Dr Reddy's Laboratories said in a statement.
"The agreement allows us to bring innovative medicines to the Russian people with active collaboration of a local pharmaceutical company-R Pharm ," Dr Reddy's MD and COO Satish Reddy said.
The collaboration is in the area of high technology and works on a profit sharing model.
"It will entail licensing of manufacturing know how of products by Dr Reddy's, local manufacturing of products in Russia, co-development of high technology products and knowledge sharing between both parties at regular intervals," it added.
The company has entered into a licencing, technology transfer, manufacturing and marketing agreement with R-Pharm of Russia, Dr Reddy's Laboratories said in a statement.
"The agreement allows us to bring innovative medicines to the Russian people with active collaboration of a local pharmaceutical company-R Pharm ," Dr Reddy's MD and COO Satish Reddy said.
The collaboration is in the area of high technology and works on a profit sharing model.
"It will entail licensing of manufacturing know how of products by Dr Reddy's, local manufacturing of products in Russia, co-development of high technology products and knowledge sharing between both parties at regular intervals," it added.
No comments:
Post a Comment